Deciphering dual clinical entities associated with <scp><i>TP53</i></scp> pathogenic variants: Insights from 53,085 <scp>HBOC</scp> panel analyses in French laboratories
Edwige Kasper(Inserm), Claude Houdayer(Inserm), Camille Charbonnier(Université de Rouen Normandie), Lisa Golmard(Université Paris Sciences et Lettres), Mathilde Gay‐Bellile(Inserm), Dominique Vaur(Centre François Baclesse), Alexandre Perrier(Assistance Publique – Hôpitaux de Paris), Patrick R. Benusiglio(Université Paris-Saclay), Hela Sassi(Institut Gustave Roussy), Jean‐Marie Ravel(Inserm), Gaëlle Bougeard(Inserm), Florence Coulet(Sorbonne Université), Etienne Rouleau(Inserm), Nicolas Sévenet, Maud Branchaud(Inserm), Pierre Vande Perre(Institut Claudius Regaud), Stéphanie Baert‐Desurmont, Emilie Bouvignies(Inserm), Noémie Basset(Sorbonne Université), Fanny Brayotel(Institut Jean Godinot), Virginie Bubien, Paul Vilquin(Université Claude Bernard Lyon 1), Chrystelle Colas(Inserm), Céline Bonnet(Inserm), Jessica Le Gall(Institut Curie), Mathis Lepage(Inserm), Ahmed Bouras(Hospices Civils de Lyon), Nathalie Parodi(Inserm), Vincent Goussot(Centre Georges François Leclerc), Olivier Caron(Université Paris-Saclay), Valentin Dérangère(Inserm), Alice Fiévet(Université Paris Sciences et Lettres), Dominique Stoppa‐Lyonnet(Centre National de la Recherche Scientifique), Céline Garrec(Centre Hospitalier Universitaire de Nantes), Anna Lokchine(Inserm), Juliette Albuisson(Délégation Paris 5), Marie Bidart(Centre National de la Recherche Scientifique), Ayman Al Saati(Centre National de la Recherche Scientifique), Marion Rolain(Inserm), Adrien Buisson(Centre Léon Bérard), Pascaline Berthet(Centre François Baclesse), Nadia Boutry‐Kryza(Hospices Civils de Lyon), Marion Gauthier‐Villars, Jean‐Christophe Théry, Laurent Castéra(Inserm), Capucine Delnatte(Centre Hospitalier Universitaire de Nantes), Flavie Boulouard(Inserm)
Cited by 4
Related Papers
<i>LMO2</i> -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
|Science|2003|3.5k
Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline <i>CDH1</i> mutation carriers
|Journal of Medical Genetics|2015|567
Hereditary diffuse gastric cancer: updated clinical practice guidelines
|The Lancet Oncology|2020|493
Characterisation of retinoblastomas without RB1 mutations: genomic, gene expression, and clinical studies
|The Lancet Oncology|2013|419
Mutations of the TGF-β type II receptorBMPR2 in pulmonary arterial hypertension
|Human Mutation|2006|404